Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Albumin and bleed risk in rivaroxaban treated patients
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Albumin and bleed risk in rivaroxaban treated patients'. Together they form a unique fingerprint.
Rivaroxaban
Medicine & Life Sciences
100%
Albumins
Medicine & Life Sciences
65%
Hemorrhage
Medicine & Life Sciences
36%
Logistic Models
Medicine & Life Sciences
24%
Hypoalbuminemia
Medicine & Life Sciences
11%
Protein Binding
Medicine & Life Sciences
9%
Action Potentials
Medicine & Life Sciences
8%
Hemoglobins
Medicine & Life Sciences
7%
Cite this